The market has since validated Guo’s conviction. On Kickstarter, Zettlab raised more than USD 1.4 million, with 80% of ...

Stage 5: Justify thinking. A vital habit that many students need to solidify is recontextualizing after they solve ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Astronomers from Keele University in the UK have utilized NASA's planet-hunting TESS telescope to investigate a ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

Expert-Backed Tips For Regowing Your Hair This article was reviewed by Knox Beasley, MD. Ask the internet how to get thicker ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.

The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...